The notion that drugs can induce valvular heart disease (VHD) has occurred since the sixties and has received a lot of attention in recent years. Overstimulation of the serotonin 2B receptor (5-HT2B) leads to valvular fibroblast proliferation and thickening of the valvular leaflets with reduced mobility and regurgitation as a consequence. This book focuses on different aspects of this distinct kind of valvulopathy including pathophysiology of drug-induced VHD, histopathological and echocardiographic characteristics,drugs associated with VHD, the influence of cumulative drug dose and risk factors and others.
Introduction; Pathophysiology of Drug-Induced Valvular Heart Disease; Morphological & Echocardiographic Characteristics; Drugs Associated with Valvular Heart Disease; Influence of Drug Dose, Treatment Duration & Risk Factors; Natural Course of Toxic Valvulopathy; Small Animal Models of Drug-Induced Valvular Heart Disease; Practical Recommendations for the Use of Potential Valvulopathic Drugs; Index.
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.